Biostorage Service Market By Type (Room Temperature Storage, Liquid Nitrogen Storage, Ultra Low-Temperature Storage, Frozen Storage, and Refrigerated Storage), By Application (Research and Development, Pharmaceuticals and Biotechnology, Diagnostics, Chemical Industry, and Others), By Sample Type (Human Samples, Animal Samples, and Microbial Samples), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Biostorage Service market accounted for USD 4.6 Billion in 2024 and is expected to reach USD 11.0 Billion by 2035, growing at a CAGR of around 8.2% between 2025 and 2035.  The biostorage services market provides solutions for storing biological materials such as cells, tissues, DNA, and other biomaterials. These solutions are commonly used in research, pharmaceuticals, and biotechnology. The services ensure the integrity and security of samples by using a controlled environment, which may include ultra-low temperature freezers and other cryogenic storage. The biostorage service market is driven by the demand for biobanking, advancements in personalized medicine, and the growth of biotechnology research and development. Biobank providers may offer additional services such as sample processing, sample management, and sample transportation, or they may solely focus on biostorage solutions. Biostorage services can be utilized by academic institutions, hospitals, and small and large biotech companies.

Report Scope:

Market Dynamics

• Driving Innovation Through Specialized Biobanking for Rare Diseases

There has been a significant increase in the use of biobanks for rare disease research. This is largely due to the growing interest in personalized medicine and targeted therapies. Rare disease researchers are increasingly relying on genetics and environmental factors to enhance their clinical knowledge of health and illness. Biobanks play a crucial role in collecting biological samples, essential for producing reliable research findings. For instance, the National Institutes of Health (NIH) has reported that around 30 million people in the United States are affected by 7,000 rare diseases, highlighting the need for more research in this area and the importance of biobanking. This growing awareness has led to increased investments in biostorage services and biobanks, as institutions recognize the significance of sample repositories for innovative approaches to patient care. Consequently, biobanks have become integral to the rare disease research ecosystem.

• Sample Integrity Concerns Pose Risks to Biostorage Market Expansion

The issue of sample degradation is a significant concern in the biostorage service market. It relates to the quality and viability of biological specimens. Key factors contributing to sample degradation include temperature variations, contamination, and storage conditions. These factors can lead to a deterioration of the samples over time, rendering them unsuitable for study or intervention.

Institutions are particularly worried about the long-term viability of biological specimens, especially when conducting sensitive research that requires high integrity. Concerns about degradation can lead to reduced investment and participation in biobanking, as stakeholders seek assurance that their samples will remain viable for future research. Addressing the challenges of sample degradation is crucial for building trust and fostering the growth of the biostorage and biobanking field.

• Empowering Research in Regional Biobanks

The development of regional biobanks presents a significant opportunity in the biostorage services market as the demand for biobanks for personalized medicine and research continues to grow. Regional biobanks simplify the collection, storage, and sharing of biological materials, allowing researchers to access data on genetics and the environment specific to a particular population. This specificity enhances the reliability of study findings, leading to improved public health outcomes and facilitating collaboration between institutions. Additionally, advancements in biostorage technologies such as cryopreservation and automated storage and inventory systems have enhanced the viability and tracking of stored biological materials. As new regulations drive the need for biobanks to store vaccines for future drug development efforts, the demand for regional biobanks and supporting technologies is expected to increase, creating new opportunities for developers in the biostorage market.

Industry Experts Opinion

“There is increased interest in stable, high-growth healthcare investments, and that can lead to partnering opportunities. GHO has built a reputation as a reference partner to management teams of healthcare businesses looking to accelerate growth and particularly where that growth is transatlantic - by that we mean taking European businesses to North America and bringing North American businesses to Europe."

-Mike Mortimer, founder and managing partner of GHO

"We built an amazing company at Masy and are thrilled to partner with the Alcami team, as our combined resources and capabilities will result in enhanced support for our customers"

-Lauri Masiello, Co-founder of Masy BioServices

Segment Analysis

Based on the type, the Biostorage Service Market has been classified into room temperature storage, liquid nitrogen storage, ultra-low temperature storage, frozen storage, and refrigerated storage.  Liquid nitrogen storage is widely used due to its ability to provide very low temperatures (-196°C) and preserve biological materials for longer periods. It does not contribute to ice crystal formation, which minimizes damage to sensitive biological materials like cells and tissues. In addition to these advantages, liquid nitrogen storage offers great stability and is subject to regulations. This method is preferred for long-term preservation of biological materials in biobanking, reproductive health, and research applications.

Based on the application, the Biostorage Service Market has been classified into research and development, pharmaceuticals and biotechnology, diagnostics, chemical industry and others. The pharmaceuticals and biotechnology industry tends to hold the largest share in the market. This is because these sectors have a critical need to maintain biological samples, cell lines, and active pharmaceutical ingredients under physical control for research, development, and manufacturing processes. These industries typically rely on liquid nitrogen and ultra-low temperature storage (ULT) for long-term product viability and shelf life, making them dominant sectors in the overall market.

Regional Analysis

The demand for biostorage services in North America is increasing due to the growing need for biological samples for clinical and research purposes. It is a diverse landscape with involvement from biobanks, pharmaceutical companies, and academic institutions. Services are specialized and sector-specific in this region. Technological advancements are expected to improve operational efficiency and sample integrity through developments in automated storage systems and better data management. High-quality biostorage solutions also require improved organizational practices. Stringent regulatory requirements drive the need for high-quality biostorage solutions. Companies involved in strategic partnerships are dominating the market, making North America a global hub for biostorage services.

In the Asia Pacific region, the market for biostorage services is growing rapidly due to increased research and clinical trials. China, India, and Japan are becoming major players due to investments in healthcare and biotechnology. There is a high demand for biobanking services as researchers and pharmaceutical companies need stable storage for biological samples. Innovations in cryopreservation technologies and data management systems are expected to boost the global biostorage services market, improving efficiency and reliability. Supportive government policies and a growing focus on personalized medicine are also contributing to market growth in the Asia-Pacific region, creating a dynamic and competitive landscape for biostorage services.

Competitive Landscape

The biostorage services market is growing due to the increasing use of biobanking and advancements in biotechnology. Major companies like Thermo Fisher Scientific, Brooks Life Sciences, and VWR International are developing solutions and technologies for storage. Tough competition was observed recently when Thermo Fisher announced the expansion of its biostorage facilities in North America for better capacity and efficiency.

Additionally, Brooks Life Sciences implemented state-of-the-art sample inventory management software to improve sample tracking and retrieval. There is also a growing trend of collaborations with clinical biobanks, with increasing investments in such partnerships. For instance, in January, 2024 Leading contract development and manufacturing organization (CDMO) Alcami Corporation ("Alcami") announced that it has successfully acquired Pacific Pharmaceutical Services, Inc. ("PPS"), a preferred supplier of cGMP pharmaceutical storage and services.

Biostorage Service Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In September 2024, SK Pharmteco, a global contract development and manufacturing organization, and Cryoport, Inc., a leader in supply chain solutions for the life sciences industry, announced a strategic partnership to offer fully integrated manufacturing and logistics services to biotechnology and pharmaceutical companies.
• In April, 2023, Leading contract development and manufacturing organization (CDO) Alcami Corporation announced that the Phase III expansion of its cGMP biostorage facility in Amherst, New Hampshire, has been completed. After the third and final phase was finished, there was 160,000 square feet of ambient cGMP biostorage capacity with 21,000 pallet locations. This capacity can now be fully utilized to support a range of cGMP client storage needs.

Report Coverage:

By Type

• Room Temperature Storage
• Liquid Nitrogen Storage
• Ultra Low Temperature Storage
• Frozen Storage
• Refrigerated Storage

By Application

• Research and Development
• Pharmaceuticals and Biotechnology
• Diagnostics
• Chemical Industry
• Others

By Sample Type

• Human Samples
• Animal Samples
• Microbial Samples

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Azenta
• Thermo Fisher Scientific
• VWR (EPL Archives)
• Precision for Medicine
• Cryoport Inc.
• Masy BioServices (Alcami)
• SciSafe (BioLife Solutions)
• Cenetron
• Vigilant Bioservices
• Kryosphere
• BioArkive
• Precision Stability Storage
• Goodwill E-health Info Co
• Tescor
• Birka BioStorage

Frequently Asked Questions (FAQs)